GQ127
GQ127 is an orally active Gαq/11 inhibitor with an IC50 of 22.6 μM. GQ127 binds directly to Gαq/11 protein and inhibits its activity. GQ127 induces Apoptosis, suppresses viability, migration and invasion of uveal melanoma cells. GQ127 increases the phosphorylation level of YAP and decreases the phosphorylation level of ERK. GQ127 inhibits the growth of uveal melanoma xenografts in mouse models. GQ127 can be used for research related to uveal melanoma.
For research use only. We do not sell to patients.
- CAS No.: 2625582-70-7
- Formula: C25H36N4O
- Molecular Weight:408.58
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MP41 | IC50 |
24.8 μM
Compound: GQ127
|
Antiproliferative activity against human MP41 cells assessed as inhibition of cell growth after 72 hrs by CCK8 assay
Antiproliferative activity against human MP41 cells assessed as inhibition of cell growth after 72 hrs by CCK8 assay
|
[PMID: 33715360] |
GQ127 (10 μM) potently inhibits Gαq/11-mediated IP1 accumulation in CHO-M1 cells, with an IC50 of 22.6 μM[1].
GQ127 potently inhibits the proliferation of UM 92.1 cells (IC50 = 10.1 μM) and MP41 cells (IC50 = 24.8 μM) in a time- and dose-dependent manner[1].
GQ127 (1.25-20 μM; 24 h) exhibits low cytotoxicity against CHO-M1 cells, with no reduction in cell viability observed after 24 h of treatment at concentrations below 20 μM[1].
GQ127 (5-30 μM; 48 h) induces apoptosis in UM 92.1 and MP41 cells in a dose-dependent manner[1].
GQ127 (5-30 μM; 48 h) significantly inhibits the migration of UM 92.1 and MP41 cells after treatment at concentrations of 15 μM and higher for 48 h[1].
GQ127 (5-30 μM; 48 h) inhibits Gαq/11-mediated tumorigenesis in UM 92.1 and MP41 cells by increasing the phosphorylation level of YAP and decreasing the phosphorylation level of ERK[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:uveal melanoma (UM) 92.1 cells, uveal melanoma (UM) MP41 cells
-
Concentration:5 μM, 15 μM (92.1 cells); 15 μM, 30 μM (MP41 cells)
-
Incubation Time:48 h
-
Result:Induced apoptosis of 92.1 cells at rates of 9.48% (5 μM) and 20.1% (15 μM).
Induced apoptosis of MP41 cells at rates of 9.74% (15 μM) and 24.1% (30 μM).
Exhibited a dose-dependent apoptotic effect.
-
Cell Line:uveal melanoma (UM) 92.1 cells, uveal melanoma (UM) MP41 cells
-
Concentration:5 μM, 15 μM (92.1 cells); 15 μM, 30 μM (MP41 cells)
-
Incubation Time:48 h
-
Result:Enhanced the phosphorylation level of YAP in both 92.1 and MP41 cells at 15 μM and 30 μM.
Inhibited the phosphorylation level of ERK in both 92.1 and MP41 cells at 15 μM and 30 μM.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (nu/nu) (male and female, 6−8 weeks old, 20−25 g, subcutaneous MP41 uveal melanoma patient-derived xenograft model)[1]
-
Dosage:10 mg/kg; 30 mg/kg
-
Administration:i.p.; daily; 21 days
-
Result:Achieved a tumor growth inhibition (TGI) of 99.0% at 30 mg/kg.
Achieved a TGI of 65.4% at 10 mg/kg.
Caused no significant changes in mouse body weight during treatment.
Induced no obvious morphological changes in heart, liver, spleen, lung, or kidney tissues via H&E staining.
Promoted phosphorylation of YAP and inhibited phosphorylation of ERK in tumor tissues at both doses.
Chemical Information
-
CAS No. 2625582-70-7
-
Molecular Weight 408.58
-
Formula C25H36N4O
-
SMILES
CC[C@@H](C)[C@H](N)C(N1CCN2C([C@@H]1CC3CCCCC3)=NC(C4=CC=CC=C4)=C2)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)